Filing Flows › Nuvation Bio (NUVB) › Product Revenue revenue
Nuvation Bio (NUVB) Product Revenue revenue by quarter
Nuvation Bio's Product Revenue revenue was $27.5M in Q3 2026 (third quarter 2026), +19% from Q2 2026. Over the last 3 quarters it ranged from $779K (Q1 2025) to $27.5M (Q3 2026).
| Quarter | Product Revenue revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $27.5M | +19% | — |
| Q2 2026 | $23.2M | 30× | — |
| Q1 2025 | $779K | — | — |
Q3 2026 at a glance
Nuvation Bio, Q3 2026: revenue $45.0M (+243% year over year), operating margin -93.9%, net loss $41.9M, operating cash flow −$38.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is Nuvation Bio's Product Revenue revenue?
Nuvation Bio's Product Revenue revenue was $27.5M in Q3 2026 (third quarter 2026), +19% from Q2 2026.
How has Nuvation Bio's Product Revenue revenue changed?
Over the last 3 quarters it ranged from $779K (Q1 2025) to $27.5M (Q3 2026).